Professor Andrew Boulle

Andrew Boulle

Professor Andrew Boulle

Dept. of Public Health & Family Medicine
TitleProfessor
NameAndrew Boulle
Work Telephone021 406 6715
Primary Email
DepartmentDept. of Public Health & Family Medicine
Other AffiliationsCIDER

Biosketch

Andrew Boulle is a Public Health Specialist with the Western Cape Department of Health and a Professor in Public Health Medicine in the School of Public Health and Family Medicine at the University of Cape Town. He works in the areas of HIV cohort epidemiology and surveillance, operations research related to services for priority health conditions, and the development of context appropriate routine health information systems.

Cleary, S., Okorafor, O., Chitha, W., Boulle, A. M., & Jikwana, S. (2005). Financing antiretroviral treatment and primary health care services. In Ijumba, P., & Barron, P. (Eds.), South African health review 2005 (pp. 58-75). Durban: Health Systems Trust.

Boulle, A. M., Kenyon, C., & Abdullah, M. (2003). A review of antiretroviral costing models in South Africa. In Moatti, J.P., Coriat, B., Souteyrand, Y., Barnett, T., Dumoulin, J., & Flori, Y. (Eds.), Economics of AIDS and Access to HIV/AIDS Care in Developing Countries. Issues and Challenges (pp. 293-310). Paris: ANRS Collection Sciences.

Davies, M. A., Tsondai, P., Tiffin, N., Eley, B., Rabie, H., Euvrard, J., Orrell, C., Prozesky, H., Wood, R., Cogill, D., Haas, A. D., Sohn, A., & Boulle, A. M. (2017). Where do HIV-infected adolescents go after transfer? – Tracking transition/transfer of HIV-infected adolescents using linkage of cohort data to a health information system platform. Journal of the International AIDS Society, 20, 17-24.

Fortuin-De Smidt, M., De Waal, R., Cohen, K., Technau, K., Stinson, K., Maartens, G., Boulle, A. M., Igumbor, E. U., & Davies, M. A. (2017). First-line antiretroviral drug discontinuations in children. PLoS One, 12, e0169762. doi:10.1371/journal.pone.0169762. Full text: http://dx.doi.org/10.1371/journal.pone.0169762

Boulle, A., & Johnson, L. (2016). Human immunodeficiency virus (HIV) infection. Infectious Disease Epidemiology, , 343.

De Waal, R., Cohen, K., Fox, M. P., Stinson, K., Maartens, G., Boulle, A. M., & Davies, M. A. (2016). Clinician compliance with laboratory monitoring and prescribing guidelines in HIV-1-infected patients receiving tenofovir. South African Medical Journal, 106, 369-71. doi:10.7196/SAMJ.2016.v106i4.10153. Full text: http://dx.doi.org/10.7196/SAMJ.2016.v106i4.10153

Johnson, L. F., Chiu, C., Myer, B. L., Davies, M. A., Dorrington, R. E., Bekker, L., Boulle, A. M., & Meyer-Rath, G. (2016). Prospects for HIV control in South Africa: a model-based analysis. Global Health Action, 9.

Johnson, L. F., Keiser, O., Fox, M. P., Tanser, F., Cornell, M., Hoffmann, C. J., Prozesky, H., Boulle, A. M., & Davies, M. A. (2016). Life expectancy trends in adults on antiretroviral treatment in South Africa. AIDS, Publish Ahead of Print. doi:10.1097/qad.0000000000001197. Full text: http://dx.doi.org/10.1097/qad.0000000000001197

Njau, B., Damian, D. J., Abdullahi, L., Boulle, A., & Mathews, C. (2016). The effects of HIV self-testing on the uptake of HIV testing and linkage to antiretroviral treatment among adults in Africa: a systematic review protocol. Systematic reviews, 5, 1.

Stewart, A., Lehloenya, R., Boulle, A. M., De Waal, R., Maartens, G., & Cohen, K. (2016). Severe antiretroviral-associated skin reactions in South African patients: a case series and case-control analysis. Pharmacoepidemiology and Drug Safety, 25, 1313-1319. doi:10.1002/pds.4067. Full text: http://dx.doi.org/10.1002/pds.4067

Stewart, A., Lehloenya, R., Boulle, A., Waal, R., Maartens, G., & Cohen, K. (2016). Severe antiretroviral-associated skin reactions in South African patients: a case series and case–control analysis. Pharmacoepidemiology and Drug Safety, .

Stinson, K., Goemaere, E., Coetzee, D., Van Cutsem, G., Hilderbrand, K., Osler, M., Hennessey, C., Wilkinson, L., Patten, G., & Cragg, C. (2016). Cohort Profile: The Khayelitsha antiretroviral programme, Cape Town, South Africa. International Journal of Epidemiology, .

Sumner, T., Houben, R., Rangaka, M., Maartens, G., Boulle, A., Wilkinson, R., & White, R. (2016). Post-Treatment Effect of Isoniazid Preventive Therapy on Tuberculosis Incidence in Hiv-Infected Individuals on Antiretroviral Therapy. AIDS (London, England), .

Vallabhaneni, S., Longley, N., Smith, M., Smith, R., Osler, M., Kelly, N., Cross, A., Boulle, A., Meintjes, G., & Govender, N. P. (2016). Evaluation of a Public-sector, Provider-initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa. Journal of acquired immune deficiency syndromes (1999), .

Cornell, M., Johnson, L. F., Schomaker, M. F., Tanser, F., Maskew, M., Wood, R., Prozesky, H., Giddy, J., Stinson, K., Egger, M., Boulle, A. M., Myer, B. L., & International Epidemiologic Databases to Evaluate, A. A. C. (2015). Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study. Lancet HIV, 2, e368-75.

Essel, V., van Vuuren, U., De Sa, A., Govender, S., Murie, K., Schlemmer, A., Gunst, C., Namane, M., Boulle, A., & de Vries, E. (2015). Auditing chronic disease care: does it make a difference?. African Journal of Primary Health Care & Family Medicine, 7. doi:10.4102/phcfm.v7i1.753. Full text: http://dx.doi.org/10.4102/phcfm.v7i1.753

Groenewald, P., Azevedo, V., Daniels, J., Evans, J., Boulle, A., Naledi, T., & Bradshaw, D. (2015). The importance of identified cause-of-death information being available for public health surveillance, actions and research. S Afr Med J, 105, 528-30. doi:10.7196/SAMJnew.8019. Full text: http://dx.doi.org/10.7196/SAMJnew.8019

Hermans, S., Boulle, A., Caldwell, J., Pienaar, D., & Wood, R. (2015). Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysis. J Int AIDS Soc, 18, 20240. doi:10.7448/IAS.18.1.20240. Full text: http://dx.doi.org/10.7448/IAS.18.1.20240

Jacob, R. A., Moyo, T., Schomaker, M. F., Abrahams, F., Pujol, B. G., & Dorfman, J. R. (2015). Anti-V3/Glycan and anti-MPER neutralizing antibodies, but not anti-V2/Glycan site antibodies, are strongly associated with greater anti-HIV-1 neutralization breadth and potency. Journal of Virology, 89(10), 5264-5275.

Johnson, L. F., Dorrington, R. E., Laubscher, R., Hoffmann, C. J., Wood, R., Fox, M. P., Cornell, M., Schomaker, M. F., Prozesky, H., Tanser, F., Davies, M. A., Boulle, A. M., & International Epidemiologic Databases to Evaluate, A. S. A. C. (2015). A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment. Journal of the International AIDS Society, 18, 20628.

Kerschberger, B., Boulle, A. M., Kranzer, K., Hilderbrand, K., Schomaker, M., Coetzee, D., Goemaere, E., & Van Cutsem, G. (2015). Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy. Journal of the International AIDS Society, 18(1), 20092. doi:10.7448/IAS.18.1.20092. Full text: http://dx.doi.org/10.7448/IAS.18.1.20092

Koller, M., Fatti, G., Chi, B. H., Keiser, O., Hoffmann, C. J., Wood, R., Prozesky, H., Stinson, K., Giddy, J., Mutevedzi, P., Fox, M. P., Law, M., Boulle, A., & Egger, M. (2015). Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes, 70, e110-119. doi:10.1097/QAI.0000000000000748. Full text: http://dx.doi.org/10.1097/QAI.0000000000000748

Lemee, N., Infante, I. C., Hubault, C., Boulle, A., Blanc, N., Boudet, N., Demange, V., & Karkut, M. G. (2015). Polarization rotation in ferroelectric tricolor PbTiO3/SrTiO3/PbZr0.2Ti0.8O3 superlattices. ACS Applied Materials & Interfaces, 7, 19906-13. doi:10.1021/acsami.5b03456. Full text: http://dx.doi.org/10.1021/acsami.5b03456

Longley, N., Jarvis, J. N., Meintjes, G., Boulle, A., Cross, A., Kelly, N., Govender, N. P., Bekker, L. G., Wood, R., & Harrison, T. S. (2015). Cryptococcal Antigen Screening in Patients Initiating ART In South Africa: A Prospective Cohort Study. Clin Infect Dis, in press. doi:10.1093/cid/civ936. Full text: http://dx.doi.org/10.1093/cid/civ936

Meintjes, G., Kerkhoff, A. D., Burton, R., Schutz, C., Boulle, A., Van Wyk, G., Blumenthal, L., Nicol, M. P., & Lawn, S. D. (2015). HIV-Related Medical Admissions to a South African District Hospital Remain Frequent Despite Effective Antiretroviral Therapy Scale-Up. Medicine (Baltimore), 94, e2269.

Oni, T., Youngblood, E., Boulle, A., McGrath, N., Wilkinson, R. J., & Levitt, N. S. (2015). Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa- a cross sectional study. BMC Infectious Diseases, 15, 20. doi:10.1186/s12879-015-0750-1. Full text: http://dx.doi.org/10.1186/s12879-015-0750-1

Bekker, L. G., Venter, F., Cohen, K., Goemare, E., Van Cutsem, G., Boulle, A., & Wood, R. (2014). Provision of antiretroviral therapy in South Africa: the nuts and bolts. Antiviral therapy, 19 Suppl 3, 105-16. doi:10.3851/IMP2905. Full text: http://dx.doi.org/10.3851/IMP2905

Boulle, A., Schomaker, M., May, M. T., Hogg, R. S., Shepherd, B. E., Monge, S., Keiser, O., Lampe, F. C., Giddy, J., Ndirangu, J., Garone, D., Fox, M., Ingle, S. M., Reiss, P., Dabis, F., Costagliola, D., Castagna, A., Ehren, K., Campbell, C., Gill, M. J., Saag, M., Justice, A. C., Guest, J., Crane, H. M., Egger, M., & Sterne, J. A. (2014). Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: A collaborative analysis of prospective studies. Plos Medicine, 11, e1001718. doi:10.1371/journal.pmed.1001718. Full text: http://dx.doi.org/10.1371/journal.pmed.1001718

Cornell, M., Lessells, R., Fox, M. P., Garone, D. B., Giddy, J., Fenner, L., Myer, B. L., Boulle, A. M., & Collaboration, I. S. A. (2014). Mortality among adults transferred and lost to follow-up from antiretroviral therapy programmes in South Africa: a multicenter cohort study. Journal of Acquired Immune Deficiency Syndromes, 67(2), e67-75. doi:10.1097/QAI.0000000000000269. Full text: http://dx.doi.org/10.1097/QAI.0000000000000269

Cox, H., Hughes, J., Daniels, J., Azevedo, V., McDermid, C., Poolman, M., Boulle, A., Goemaere, E., & Van Cutsem, G. (2014). Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa. International Journal of Tuberculosis and Lung Disease, 18, 441-8. doi:10.5588/ijtld.13.0742. Full text: http://dx.doi.org/10.5588/ijtld.13.0742

Davies, M. A., May, M., Bolton-Moore, C., Chimbetete, C., Eley, B. S., Garone, D., Giddy, J., Moultrie, H., Ndirangu, J., Phiri, S., Rabie, H., Technau, K. G., Wood, R., Boulle, A. M., Egger, M., Keiser, O., & Collaboration, I. S. A. (2014). Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programs. Pediatric Infectious Disease Journal, 33(6), 608-616.

Ford, N., Stinson, K., Davies, M. A., Cox, V. A., Patten, G., Cragg, C. D., Van Cutsem, G., & Boulle, A. M. (2014). Is it safe to drop CD4+ monitoring among virologically suppressed patients: a cohort evaluation from Khayelitsha, South Africa. AIDS, 28, 2003-2005. doi:10.1097/QAD.0000000000000406. Full text: http://dx.doi.org/10.1097/QAD.0000000000000406

Johnson, L. F., Estill, J., Keiser, O., Cornell, M., Moolla, H., Schomaker, M. F., Grimsrud, A. T., Davies, M. A., & Boulle, A. M. (2014). Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention?. American Journal of Epidemiology, 180(12), 1208-1212.

Leon, N., Mathews, C., Lewin, S., Osler, M., Boulle, A., & Lombard, C. (2014). A comparison of linkage to HIV care after provider-initiated HIV testing and counselling (PITC) versus voluntary HIV counselling and testing (VCT) for patients with sexually transmitted infections in Cape Town, South Africa. BMC Health Services Research, 14, 350. doi:10.1186/1472-6963-14-350. Full text: http://dx.doi.org/10.1186/1472-6963-14-350

Osler, M., Hilderbrand, K., Hennessey, C., Arendse, J., Goemaere, E., Ford, N., & Boulle, A. (2014). A three-tier framework for monitoring antiretroviral therapy in high HIV burden settings. Journal of the International AIDS Society, 17, 18908. doi:10.7448/IAS.17.1.18908. Full text: http://dx.doi.org/10.7448/IAS.17.1.18908

Patten, G. E., Cox, V., Stinson, K., Boulle, A. M., & Wilkinson, L. S. (2014). Advanced HIV disease at antiretroviral therapy (ART) initiation despite implementation of expanded ART eligibility guidelines during 2007-2012 in Khayelitsha, South Africa. Clinical Infectious Diseases, 59, 456-457. doi:10.1093/cid/ciu288. Full text: http://dx.doi.org/10.1093/cid/ciu288

Rangaka, M. X., Wilkinson, R. J., Boulle, A., Glynn, J. R., Fielding, K., Van Cutsem, G., Wilkinson, K. A., Goliath, R., Mathee, S., Goemaere, E., & Maartens, G. (2014). Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial. Lancet, 384, 682-690. doi:10.1016/S0140-6736(14)60162-8. Full text: http://dx.doi.org/10.1016/S0140-6736(14)60162-8

Schomaker, M. F., Gsponer, T., Estill, J., Fox, M., & Boulle, A. M. (2014). Non-ignorable loss to follow-up: correcting mortality estimates based on additional outcome ascertainment. Statistics in Medicine, 33(1), 129-142.

Stinson, K., Ford, N., Cox, V., & Boulle, A. (2014). Patients lost to care are more likely to be viremic than patients still in care. Clinical Infectious Diseases, 58, 1344-1345. doi:10.1093/cid/ciu072. Full text: http://dx.doi.org/10.1093/cid/ciu072

Wandeler, G., Gerber, F., Rohr, J., Chi, B. H., Orrell, C., Chimbetete, C., Prozesky, H., Boulle, A., Hoffmann, C. J., Gsponer, T., Fox, M. P., Zwahlen, M., Egger, M., & Ie, D. E. A. S. A. (2014). Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa. Antiviral therapy, 19, 521-5. doi:10.3851/IMP2710. Full text: http://dx.doi.org/10.3851/IMP2710

Bernhardt, G. L., Cameron, N. A., Willems, B., Boulle, A., & Coetzee, D. (2013). Measles vaccination coverage in high-incidence areas of the Western Cape, following the mass vaccination campaign. South African Medical Journal, 103, 181-186. doi:10.7196/samj.6196. Full text: http://dx.doi.org/10.7196/samj.6196

Davies, M. A., Phiri, S., Wood, R., Wellington, M., Cox, V. A., Bolton-Moore, C., Timmerman, V., Moultrie, H., Ndirangu, J., Rabie, H., Technau, K., Giddy, J., Maxwell, N. J., Boulle, A. M., Keiser, O., Egger, M., & Eley, B. S. (2013). Temporal trends in the characteristics of children at antiretroviral therapy initiation in Southern Africa: The IeDEA-SA collaboration. PLoS One, 8, -. doi:10.1371/journal.pone.0081037. Full text: http://dx.doi.org/10.1371/journal.pone.0081037

Estill, J., Egger, M., Johnson, L. F., Gsponer, T., Wandeler, G., Davies, M. A., Boulle, A. M., Wood, R., Garone, D., Stringer, J. S., Hallett, T. B., & Keiser, O. (2013). Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study. PLoS One, 8, e57611. doi:10.1371/journal.pone.0057611. Full text: http://dx.doi.org/10.1371/journal.pone.0057611

Fenner, L., Reid, S. E., Fox, M. P., Garone, D., Wellington, M., Prozesky, H., Zwahlen, M., Schomaker, M. F., Wandeler, G., Kancheya, N., Boulle, A. M., Wood, R., Henostroza, G., & Egger, M. (2013). Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa. Tropical Medicine & International Health, 18, 194-198.

Garone, D. B., Conradie, K., Patten, G., Cornell, M., Goemaere, W., Kunene, J., Kerschberger, B., Ford, N., Boulle, A. M., & Van Cutsem, G. (2013). High rate of virological re-suppression among patients failing second-line antiretroviral therapy following enhanced adherence support: A model of care in Khayelitsha, South Africa. Southern African Journal of HIV medicine, 14, 170-176.

Grimsrud, A. T., Cornell, M., Egger, M., Boulle, A. M., & Myer, B. L. (2013). Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: variation in the definition can have an appreciable impact on estimated proportions of LTFU. Journal of Clinical Epidemiology, 66(9), 1006-1013. doi:10.1016/j.jclinepi.2013.03.013. Full text: http://dx.doi.org/10.1016/j.jclinepi.2013.03.013

Luque-Fernandez, M. A., Van Cutsem, G., Goemaere, E. A., Hilderbrand, K. L., Schomaker, M. F., Mantangana, N., Mathee, S., Dubula, V., Ford, N., Hernan, M. A., & Boulle, A. M. (2013). Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS One, 8, e56088.

Maskew, M., Fox, M. P., Van Cutsem, G., Chu, K., MacPhail, P., Boulle, A., Egger, M., & Africa, F. I. (2013). Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study. PLoS One, 8. doi:10.1371/journal.pone.0064392. Full text: http://dx.doi.org/10.1371/journal.pone.0064392

Schomaker, M. F., Egger, M., Maskew, M., Garone, D., Prozesky, H., Hoffmann, C. J., Boulle, A. M., & Fenner, L. (2013). Immune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa. Journal of Acquired Immune Deficiency Syndromes, 63(1), 142-145.

Ajose, O., Mookerjee, S., Mills, E. J., Boulle, A., & Ford, N. (2012). Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. AIDS, 26, 929-38. doi:10.1097/QAD.0b013e328351f5b2. Full text: http://dx.doi.org/10.1097/QAD.0b013e328351f5b2

Calmy, A., Balestre, E., Bonnet, F., Boulle, A., Sprinz, E. E., Wood, R., Delaporte, E., Messou, E., Mcintyre, J., Marhoum El Filaili, K., Schechter, M., Kumarasamy, N., Bangsberg, D., McPhail, P., van der Borght, S., Zala, C., Egger, M., Thiebaut, R., & Dabis, F. (2012). Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings. BMC Infectious Diseases, 12, 147. doi:10.1186/1471-2334-12-147. Full text: http://dx.doi.org/10.1186/1471-2334-12-147

Cornell, M., Schomaker, M. F., Garone, D. B., Giddy, J., Hoffmann, C. J., Lessells, R., Maskew, M., Prozesky, H., Wood, R., Johnson, L. F., Egger, M., Boulle, A. M., & Myer, B. L. (2012). Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: A multicentre cohort study. Plos Medicine, 9, e1001304.

Davies, M. A., Boulle, A. M., Technau, K., Eley, B. S., Moultrie, H., Rabie, H., Garone, D., Giddy, J., Wood, R., Egger, M., & Keiser, O. (2012). The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure. Tropical Medicine & International Health, 17(11), 1386-1390. doi:10.1111/j.1365-3156.2012.03073.x. Full text: http://dx.doi.org/10.1111/j.1365-3156.2012.03073.x

Egger, M., Ekouevi, D. K., Williams, C., Lyamuya, R. E., Mukumbi, H., Braitstein, P., Hartwell, T., Graber, C., Chi, B. H., Boulle, A., Dabis, F., & Wools-Kaloustian, K. (2012). Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. International Journal of Epidemiology, 41, 1256-1264. doi:10.1093/ije/dyr080. Full text: http://dx.doi.org/10.1093/ije/dyr080

Fairall, L., Bachmann, M. O., Lombard, C., Timmerman, V., Uebel, K., Zwarenstein, M., Boulle, A., Georgeu, D., Colvin, C. J., Lewin, S., Faris, G., Cornick, R., Draper, B., Tshabalala, M., Kotze, E., van Vuuren, C., Steyn, D., Chapman, R., & Bateman, E. (2012). Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial. Lancet, 380. doi:10.1016/S0140-6736(12)60730-2. Full text: http://dx.doi.org/10.1016/S0140-6736(12)60730-2

Fox, M. P., Cutsem, G. V., Giddy, J., Maskew, M., Keiser, O., Prozesky, H., Wood, R., Hernan, M. A., Sterne, J. A., Egger, M., & Boulle, A. (2012). Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa. Journal of Acquired Immune Deficiency Syndromes, 60, 428-437. doi:10.1097/QAI.0b013e3182557785. Full text: http://dx.doi.org/10.1097/QAI.0b013e3182557785

Gsponer, T., Petersen, M., Egger, M., Phiri, S., Maathuis, M. H., Boulle, A., Musondad, P., Tweya, H., Peter, K., Chi, B. H., & Keiser, O. (2012). The causal effect of switching to second-line ART in programmes without access to routine viral load monitoring. AIDS, 26, 57-65. doi:10.1097/QAD.0b013e32834e1b5f. Full text: http://dx.doi.org/10.1097/QAD.0b013e32834e1b5f

Kerschberger, B., Hilderbrand, K., Boulle, A. M., Coetzee, D., Goemaere, E., De Azevedo, V., & Van Cutsem, G. (2012). The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study. PLoS One, 7, e46988. doi:10.1371/journal.pone.0046988. Full text: http://dx.doi.org/10.1371/journal.pone.0046988

Meintjes, G., & Boulle, A. (2012). Immune reconstitution inflammatory syndrome in a large multicenter cohort study: case definition and comparability. Expert Review of Anti-infective Therapy, 10(7), 737-741. doi:10.1586/eri.12.62. Full text: http://dx.doi.org/10.1586/eri.12.62

Rangaka, M. X., Gideon, H. P., Wilkinson, K. A., Pai, M., Mwansa-Kambafwile, J., Maartens, G., Glynn, J. R., Boulle, A., Fielding, K., Goliath, R., Titus, R., Mathee, S., & Wilkinson, R. J. (2012). Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms. European Respiratory Journal, 39(1), 163-171. doi:10.1183/09031936.00058911. Full text: http://dx.doi.org/10.1183/09031936.00058911

Rangaka, M. X., Wilkinson, R. J., Glynn, J. R., Boulle, A., Van Cutsem, G., Goliath, R., Mathee, S., & Maartens, G. (2012). Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. Clinical Infectious Diseases, 55(12), 1698-1706. doi:10.1093/cid/cis775. Full text: http://dx.doi.org/10.1093/cid/cis775

Stinson, K., Boulle, A., Smith, P. J., Stringer, E. M., Stringer, J. S., & Coetzee, D. (2012). Coverage of the prevention of mother-to-child transmission program in the Western Cape, South Africa using cord blood surveillance. Journal of Acquired Immune Deficiency Syndromes, 60, 199-204. doi:10.1097/QAI.0b013e31824d985e. Full text: http://dx.doi.org/10.1097/QAI.0b013e31824d985e

Wandeler, G., Keiser, O., Mulenga, L., Hoffmann, C. J., Wood, R., Chaweza, T., Brennan, A., Prozesky, H., Garone, D., Giddy, J., Chimbetete, C., Boulle, A., & Egger, M. (2012). Tenofovir in Second-Line ART in Zambia and South Africa: Collaborative Analysis of Cohort Studies. Journal of Acquired Immune Deficiency Syndromes, 61, 41-48. doi:10.1097/QAI.0b013e3182632540. Full text: http://dx.doi.org/10.1097/QAI.0b013e3182632540

Wearne, N., Swanepoel, C. R., Boulle, A., Duffield, M. S., & Rayner, B. L. (2012). The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 11(27), 4109-4118. doi:10.1093/ndt/gfr702. Full text: http://dx.doi.org/10.1093/ndt/gfr702

Yiannoutsos, C. T., Johnson, L. F., Boulle, A. M., Musick, B. S., Gsponer, T., Balestre, E., Law, M., Shepherd, B. E., & Egger, M. (2012). Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy. Sexually Transmitted Infections, 88 Suppl 2, i33-43. doi:10.1136/sextrans-2012-050658. Full text: http://dx.doi.org/10.1136/sextrans-2012-050658

Zhou, J., Jacquet, A., Bissagnene, E., Musick, B., Wools-Kaloustian, K., Maxwell, N. J., Boulle, A. M., Wehbe, F., Masys, D., Iriondo-Perez, J., Hemingway-Foday, J., Law, M. G., & To Evaluate Aids Iedea, F. T. (2012). Short-term risk of anemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries from sub-Saharan Africa, Asia-Pacific, and Central and South America. Journal of the International AIDS Society, 15, 5. doi:10.1186/1758-2652-15-5. Full text: http://dx.doi.org/10.1186/1758-2652-15-5

Cornell, M., Grimsrud, A. T., Boulle, A. M., & Myer, B. L. (2011). Retention among adults initiating antiretroviral therapy in South Africa: 2002-2007. Journal of Acquired Immune Deficiency Syndromes, 56(3), e102-103. doi:10.1097/QAI.0b013e318202c40e. Full text: http://dx.doi.org/10.1097/QAI.0b013e318202c40e

Davies, M. A., Boulle, A. M., Eley, B. S., Moultrie, H., Technau, K., Rabie, H., Van Cutsem, G., Giddy, J., Wood, R., Egger, M., & Keiser, O. (2011). Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - The IeDEA Southern Africa collaboration. Tropical Medicine & International Health, 16(11), 1367-1371. doi:10.1111/j.1365-3156.2011.02854.x. Full text: http://dx.doi.org/10.1111/j.1365-3156.2011.02854.x

Davies, M. A., Moultrie, H., Eley, B. S., Rabie, H., Van Cutsem, G., Giddy, J., Wood, R., Technau, K., Keiser, O., Egger, M., & Boulle, A. M. (2011). Virologic Failure and Second-Line Antiretroviral Therapy in Children in South Africa-The IeDEA Southern Africa Collaboration. Journal of Acquired Immune Deficiency Syndromes, 56, 0-0. doi:10.1097/QAI.0b013e3182060610. Full text: http://dx.doi.org/10.1097/QAI.0b013e3182060610

Fenner, L., Forster, M., Boulle, A., Phiri, S., Braitstein, P., Lewden, C., Schechter, M., Kumarasamy, N., Pascoe, M., Sprinz, E., Bangsberg, D. R., Sow, P. S., Dickinson, D., Fox, M. P., Mcintyre, J., Khongphatthanayothin, M., Dabis, F., Brinkhof, M. W., Wood, R., & Egger, M. (2011). Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. International Journal of Tuberculosis and Lung Disease, 15, 620-627. doi:10.5588/ijtld.10.0249. Full text: http://dx.doi.org/10.5588/ijtld.10.0249

Keiser, O., Chi, B. H., Gsponer, T., Boulle, A. M., Orrell, C., Phiri, S., Maxwell, N. J., Maskew, M., Prozesky, H., Fox, M. P., Westfall, A., & Egger, M. (2011). Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa. AIDS, 25(14), 1761-1769. doi:10.1097/QAD.0b013e328349822f. Full text: http://dx.doi.org/10.1097/QAD.0b013e328349822f

Lawn, S. D., Campbell, L., Kaplan, R., Boulle, A. M., Cornell, M., Kerschberger, B., Morrow, C., Little, F., Egger, M., & Wood, R. (2011). Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa. Journal of Acquired Immune Deficiency Syndromes, 57, 136-140. doi:10.1097/QAI.0b013e3182199ee9. Full text: http://dx.doi.org/10.1097/QAI.0b013e3182199ee9

Rangaka, M. X., Gideon, H. P., Wilkinson, K. A., Pai, M., Mwansa-Kambafilwe, J., Maartens, G., Glynn, J. R., Boulle, A., Fielding, K., Goliath, R., Titus, R., Mathee, S., & Wilkinson, R. J. (2011). No discriminatory value of interferon release added to smear negative HIV-tuberculosis algorithms. European Respiratory Journal, 47(2).

Schoni-Affolter, F., Keiser, O., Mwango, A., Stringer, J., Ledergerber, B., Mulenga, L., Bucher, H. C., Westfall, A. O., Calmy, A., Boulle, A., Chintu, N., Egger, M., & Chi, B. H. (2011). Estimating Loss to follow-up in HIV-infected patients on antiretroviral therapy: The effect of the competing risk of death in Zambia and Switzerland. PLoS One, 6, e27919. doi:10.1371/journal.pone.0027919. Full text: http://dx.doi.org/10.1371/journal.pone.0027919

Van Cutsem, G., Ford, N., Hildebrand, K., Goemaere, E., Mathee, S., Abrahams, M., Coetzee, D., & Boulle, A. (2011). Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: A cohort analysis. PLoS One, 6, e14684.

Asselman, V., Thienemann, F., Pepper, D. J., Boulle, A., Wilkinson, R. J., Meintjes, G., & Marais, S. (2010). Central nervous system disorders after starting antiretroviral therapy in South Africa. AIDS, 24, 2871-6. doi:10.1097/QAD.0b013e328340fe76. Full text: http://dx.doi.org/10.1097/QAD.0b013e328340fe76

Boulle, A. M., Van Cutsem, G., Hilderbrand, K. L., Cragg, C. D., Abrahams, M., Mathee, S., Ford, N., Knight, L., Osler, M., Myers, J. E., Goemaere, E. A., Coetzee, D. J., & Maartens, G. (2010). Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS, 24. doi:10.1097/QAD.0b013e328333bfb7. Full text: http://dx.doi.org/10.1097/QAD.0b013e328333bfb7

Boulle, A., Clayden, P., Cohen, K., Cohen, T., Conradie, F., Dong, K., Geffen, N., Grimwood, A., Hurtado, R., Kenyon, C., Lawn, S., Maartens, G., Meintjes, G., Mendelson, M., Murray, M., Rangaka, M., Sanne, I., Spencer, D., Taljaard, J., Variava, E., Venter, W. D., & Wilson, D. (2010). Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality?. South African Medical Journal, 100, 566, 568, 570-571.

Brinkhof, M. W., Spycher, B. D., Yiannoutsos, C., Weigel, R., Wood, R., Messou, E., Boulle, A., Egger, M., & Sterne, J. A. (2010). Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. PLoS One, 5, e14149. doi:10.1371/journal.pone.0014149. Full text: http://dx.doi.org/10.1371/journal.pone.0014149

Chu, K. M., Boulle, A. M., Ford, N., Goemaere, E., Asselman, V., & Van Cutsem, G. (2010). Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa. PLoS One, 5, e9183. doi:10.1371/journal.pone.0009183. Full text: http://dx.doi.org/10.1371/journal.pone.0009183

Chu, K. M., Mahlangeni, G., Swannet, S., Ford, N. P., Boulle, A., & Van Cutsem, G. (2010). AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa. Journal of the International AIDS Society, 13, 23.

Clayden, P., Black, V., Boulle, A., Coovadia, A. H., & Venter, F. (2010). Efavirenz in pregnancy. Southern African Journal of HIV medicine, 11, 24-29.

Cornell, M., Grimsrud, A. T., Fairall, L. R., Fox, M. P., Van Cutsem, G., Giddy, J., Wood, R., Prozesky, H., Mohapi, L., Graber, C., Egger, M., Boulle, A. M., & Myer, B. L. (2010). Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS, 24. doi:10.1097/QAD.0b013e32833d45c5. Full text: http://dx.doi.org/10.1097/QAD.0b013e32833d45c5

Ford, N., Darder, M., Spelman, T., Maclean, E., Mills, E., & Boulle, A. (2010). Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohort. PLoS One, 5, e10460. doi:10.1371/journal.pone.0010460. Full text: http://dx.doi.org/10.1371/journal.pone.0010460

Keiser, O., Tweya, H., Braitstein, P., Dabis, F., MacPhail, P., Boulle, A., Nash, D., Wood, R., Luthi, R., Brinkhof, M. W., Schechter, M., & Egger, M. (2010). Mortality after failure of antiretroviral therapy in sub-Saharan Africa. Tropical Medicine & International Health, 15, 251-258.

Kenyon, C., Boulle, A., Badri, M., & Asselman, V. (2010). I don't use a condom (with my regular partner) because I know that I'm faithful, but with everyone else I do: The cultural and socioeconomic determinants of sexual partner concurrency in young South Africans. SAHARA-J - Social Aspects of HIV/AIDS, 7, 35-43.

May, M., Boulle, A. M., Phiri, S., Messou, E., Myer, B. L., Wood, R., Keiser, O., Sterne, J. A., Dabis, F., & Egger, M. (2010). Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet, 376.

Meintjes, H., Hall, K., Marera, D. H., & Boulle, A. (2010). Orphans of the AIDS epidemic? The extent, nature and circumstances of child-headed households in South Africa. Aids Care, 22(1), 40-49.

Osler, M., Stead, D., Rebe, K., Meintjes, G., & Boulle, A. (2010). Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study. HIV Medicine, 11, 121-9.

Ross, I., Boulle, A., Soule, S., Levitt, N., Pirie, F., Karlsson, A., Mienie, J., Yang, P., Wang, H., She, J. X., Winter, W., & Schatz, D. (2010). Autoimmunity predominates in a large South African cohort with addison's disease of mainly European descent despite long-standing disease and is associated with HLA DQB*0201. Clinical Endocrinology, 73(3), 291-298.

Schutz, C., Boulle, A., Stead, D., Rebe, K., Osler, M., & Meintjes, G. (2010). Reduced referral and case fatality rates for severe symptomatic hyperlactataemia in a South African public sector antiretroviral programme: a retrospective observational study. AIDS Research and Therapy, 7, 13.

Allen, E. N., Little, F., Camba, T., Cassam, Y., Raman, J., Boulle, A., & Barnes, K. I. (2009). Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial. Malaria Journal, 8, 141.

Boulle, A., & Eley, B. (2009). Commentary: Reducing HIV-associated tuberculosis in children. International Journal of Epidemiology, 38, 162-163.

Brinkhof, M. W., Boulle, A., Weigel, R., Messou, E., Mathers, C., Orrell, C., Dabis, F., Pascoe, M., & Egger, M. (2009). Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. Plos Medicine, 6, e1000066. doi:10.1371/journal.pmed.1000066. Full text: http://dx.doi.org/10.1371/journal.pmed.1000066

Cornell, M., Technau, K., Fairall, L. R., Wood, R., Moultrie, H., Van Cutsem, G., Giddy, J., Mohapi, L., Eley, B. S., MacPhail, P., Prozesky, H., Rabie, H., Davies, M. A., Maxwell, N. J., & Boulle, A. M. (2009). Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration. South African Medical Journal, 99, -.

Davies, M. A., Egger, M., Keiser, O., & Boulle, A. M. (2009). Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies. African Journal of AIDS Research, 8(3), 329-338. doi:10.2989/AJAR.2009.8.3.9.930. Full text: http://dx.doi.org/10.2989/AJAR.2009.8.3.9.930

Davies, M. A., Keiser, O., Technau, K., Eley, B. S., Rabie, H., Van Cutsem, G., Giddy, J., Wood, R., Boulle, A. M., Egger, M., & Moultrie, H. (2009). Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. South African Medical Journal, 99, 0-0.

Jarvis, J. N., Boulle, A., Loyse, A., Bicanic, T., Rebe, K., Williams, A., Harrison, T. S., & Meintjes, G. (2009). High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out. AIDS, 23, 1182-3. doi:10.1097/QAD.0b013e32832be0fc. Full text: http://dx.doi.org/10.1097/QAD.0b013e32832be0fc

Keiser, O., MacPhail, P., Boulle, A., Wood, R., Schechter, M., Dabis, F., Sprinz, E., & Egger, M. (2009). Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy. Tropical Medicine & International Health, 14, 1220-1225.

Keiser, O., Tweya, H., Boulle, A., Braitstein, P., Schecter, M., Brinkhof, M. W., Dabis, F., Tuboi, S., Sprinz, E., Pujades-Rodriguez, M., Calmy, A., Kumarasamy, N., Nash, D., Jahn, A., MacPhail, P., Luthy, R., Wood, R., & Egger, M. (2009). Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring. AIDS, 23, 1867-1874. doi:10.1097/QAD.0b013e32832e05b2. Full text: http://dx.doi.org/10.1097/QAD.0b013e32832e05b2

Arrivé, E., Kyabayinze, D. J., Marquis, B., Tumwesigye, N., Kieffer, M. P., Azondekon, A., Wemin, L., Fassinou, P., Newell, M. L., Leroy, V., Abrams, E. J., Cotton, M., Boulle, A., Mbori-Ngacha, D., & Dabis, F. (2008). Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration. International Journal of Epidemiology, 37, 474-480.

Bock, P., Boulle, A., White, C., Osler, M., & Eley, B. (2008). Provision of antiretroviral therapy to children within the public sector of South Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 102, 905-911.

Boulle, A., Bock, P., Osler, M., Cohen, K., Channing, L., Hilderbrand, K., Mothibi, E., Zweigenthal, V., Slingers, N., Cloete, K., & Abdullah, F. (2008). Antiretroviral therapy and early mortality in South Africa. Bulletin of the World Health Organization, 86, 678-687.

Boulle, A., Hilderbrand, K., Menten, J., Coetzee, D., Ford, N., Matthys, F., Boelaert, M., & Van der Stuyft, P. (2008). Exploring HIV risk perception and behaviour in the context of antiretroviral treatment: results from a township household survey. Aids Care, 20, 771-781.

Boulle, A., Van Cutsem, G., Cohen, K., Hilderbrand, K., Mathee, S., Abrahams, M., Goemaere, E., Coetzee, D., & Maartens, G. (2008). Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy. Journal of the American Medical Association, 300, 530-539.

Braitstein, P., Boulle, A., Nash, D., Brinkhof, M. W., Dabis, F., Laurent, C., Schechter, M., Tuboi, S. H., Sprinz, E., Miotti, P., Hosseinipour, M., May, M., Egger, M., Bangsberg, D. R., & Low, N. (2008). Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. Journal of Womens Health, 17, 47-55. doi:10.1089/jwh.2007.0353. Full text: http://dx.doi.org/10.1089/jwh.2007.0353

Brinkhof, M. W., Dabis, F., Myer, B. L., Bangsberg, D. R., Boulle, A. M., Nash, D., Schechter, M., Laurent, C., Keiser, O., May, M., Sprinz, E., Egger, M., & Anglaret, X. (2008). Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ, 86.

Cleary, S. M., Boulle, A., Castillo-Riquelme, M., & Mcintyre, J. (2008). The Burden of HIV/AIDS in the Public Sector Healthcare System. South African Journal of Economics, 76, S3-S14.

Cleary, S. M., McIntyre, D., & Boulle, A. M. (2008). Assessing efficiency and costs of scaling up HIV treatment. AIDS, 22 Suppl 1, S35-42.

Cohen, K., Van Cutsem, G., Boulle, A., McIlleron, H., Goemaere, E., Smith, P. J., & Maartens, G. (2008). Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis. Journal of Antimicrobial Chemotherapy, 61, 389-393.

Davies, M. A., Boulle, A. M., Fakir, T., Nuttall, J. J., & Eley, B. S. (2008). Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatrics, 8, 0-0.

Egger, M., & Boulle, A. (2008). Population effect of scaling up ART in resource-poor settings. Lancet, 371, 1558-1559.

Fairall, L. R., Bachmann, M. O., Louwagie, G. M., van Vuuren, C., Chikobvu, P., Steyn, D., Staniland, G. H., Timmerman, V., Msimanga, M., Seebregts, C. J., Boulle, A., Nhiwatiwa, R., Bateman, E. D., Zwarenstein, M. F., & Chapman, R. D. (2008). Effectiveness of antiretroviral treatment in a South African program: a cohort study. Archives of Internal Medicine, 168, 86-93.

Fairall, L. R., Bachmann, M. O., Zwarenstein, M. F., Lombard, C. J., Uebel, K., van Vuuren, C., Steyn, D., Boulle, A., & Bateman, E. D. (2008). Streamlining tasks and roles to expand treatment and care for HIV: randomised controlled trial protocol. Trials, 9, 21.

Forster, M., Bailey, C., Brinkhof, M. W., Graber, C., Boulle, A., Spohr, M., Balestre, E., May, M., Keiser, O., Jahn, A., & Egger, M. (2008). Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bulletin of the World Health Organization, 86, 939-947.

Jaspan, H. B., Berrisford, A. E., & Boulle, A. (2008). Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program. Pediatric Infectious Disease Journal, 11. doi:10.1097/INF.0b013e31817acf7b. Full text: http://dx.doi.org/10.1097/INF.0b013e31817acf7b

Keiser, O., Anastos, K., Schechter, M., Balestre, E., Myer, B. L., Boulle, A. M., Bangsberg, D., Toure, H., Braitstein, P., Sprinz, E., Nash, D., Hosseinipour, M., Dabis, F., May, M., Brinkhof, M. W., & Egger, M. (2008). Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Tropical Medicine & International Health, 13.

Keiser, O., Orrell, C., Egger, M., Wood, R., Brinkhof, M. W., Furrer, H., Van Cutsem, G., Ledergerber, B., & Boulle, A. (2008). Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared. Plos Medicine, 5, e148.

Kenyon, C., Ford, N., & Boulle, A. (2008). When best practice is bad medicine: a new approach to rationing tertiary health services in South Africa. South African Medical Journal, 98, 350, 352, 354 passim.

Stead, D., Osler, M., Boulle, A., Rebe, K., & Meintjes, G. (2008). Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa. Antiviral therapy, 13, 937-43.

Stringer, E. M., Chi, B. H., Chintu, N., Creek, T. L., Ekouevi, D. K., Coetzee, D., Tih, P., Boulle, A., Dabis, F., Shaffer, N., Wilfert, C. M., & Stringer, J. S. (2008). Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countries. Bulletin of the World Health Organization, 86, 57-62.

Boulle, A. M., & Ford, N. (2007). Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges?. Sexually Transmitted Infections, 83, 503-505.

Boulle, A. M., Orrell, C., Kaplan, R. J., Van Cutsem, G., McNally, M., Hilderbrand, K. L., Myer, B. L., Egger, M., Coetzee, D. J., Maartens, G., & Wood, R. (2007). Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. Antiviral therapy, 12, 753-760.

Brinkhof, M. W., Egger, M., Boulle, A. M., May, M., Hosseinipour, M., Sprinz, E., Braitstein, P., Dabis, F., Reiss, P., Bangsberg, D. R., Rickenbach, M., Miro, J. M., Myer, B. L., Mocroft, A., Nash, D., Keiser, O., Pascoe, M., van der Borght, S., & Schechter, M. (2007). Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clinical Infectious Diseases, 45, 1518-1521.

Deacon, H., & Boulle, A. M. (2007). Commentary: Factors affecting HIV/AIDS-related stigma and discrimination by medical professionals. International Journal of Epidemiology, 36, 185-186.

Maartens, G., & Boulle, A. M. (2007). CD4 T-cell responses to combination antiretroviral therapy. Lancet, 370, 366-368.

Saranchuk, P., Boulle, A. M., Hilderbrand, K. L., Coetzee, D. J., Bedelu, M., Van Cutsem, G., & Meintjes, G. A. (2007). Evaluation of a diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV-infected adults. South African Medical Journal, 97, 517-523.

Boulle, A. M., & Coetzee, D. J. (2006). Anticipating future challenges to ART provision in South Africa: Reflections on the Khayelitsha ART programme. Acta Academica, 1, 0-0.

Cleary, S. M., McIntyre, D., & Boulle, A. M. (2006). The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis. Cost Effectiveness and Resource Allocation, 4, 20.

Coetzee, D. J., Hilderbrand, K. L., Boulle, A. M., Draper, B., Abdullah, F., & Goemaere, E. A. (2005). Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Bulletin of the World Health Organization, 83, 0-0.

Dabis, F., Balestre, E., Braitstein, P., Miotti, P., Brinkhof, W. G., Schneider, M., Schechter, M., Laurent, C., Boulle, A. M., Kabugo, C., Capkun, G., Seyler, C., McIntyre, J. A., Sprinz, E., Bangsberg, D., van der Borght, S., & Egger, M. (2005). Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts. International Journal of Epidemiology, 34, 0-0.

Egger, M., Boulle, A. M., Schechter, M., & Miotti, P. (2005). Antiretroviral therapy in resource-poor settings: scaling up inequalities?. International Journal of Epidemiology, 34, 0-0.

Boulle, A., Coetzee, D., & Darder, M. (2004). Reflections and challannges after four years of HIV services in Khayelitsha. South African Journal of HIV Medicine, 5(2), 220-024.

Coetzee, D. J., Boulle, A. M., Hilderbrand, K. L., Asselman, V., Van Cutsem, G., & Goemaere, E. A. (2004). Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS, 18 Suppl 3, 0-0.

Coetzee, D. J., Hilderbrand, K. L., Boulle, A. M., Maartens, G., Louis, F., Labatala, V., Reuter, H., Ntwana, N., & Goemaere, E. A. (2004). Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS, 18, 0-0.

Kasper, T., Coetzee, D. J., Louis, F., Boulle, A. M., & Hilderbrand, K. L. (2003). Demystifying antiretroviral therapy in resource-poor settings. Essential Drugs Monitor, 32, 20-21.

Kenyon, C., Skordis-Worrall, J., Boulle, A. M., & Pillay, K. (2003). The ART of rationing--the need for a new approach to rationing health interventions. South African Medical Journal, 93(1), 56-60.

Myers, J. E., Thompson, M. L., Ramushu, S., Young, T., Jeebhay, M. F., London, L., Esswein, E., Renton, K., Spies, A., Boulle, A. M., Naik, I., Iregren, A., & Rees, D. J. (2003). The nervous system effects of occupational exposure on workers in a South African manganese smelter. Neurotoxicology, 26(6), 993-1000.

Boulle, A. M., Kenyon, C., Skordis-Worrall, J., & Wood, R. (2002). Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa. South African Medical Journal, 92(10), 811-817.

Boulle, A. M., Chandramohan, D., & Weller, P. (2001). A case study of using artificial neural networks for classifying cause of death from verbal autopsy. International Journal of Epidemiology, 30, 515-520.

Osler, M., Bock, P., White, C., Cloete, K., Smuts, B., Slingers, N., Zweigenthal, V., Naidoo, P., Van Niekerk, L., Channing, L., Cragg, C. D., Kredo, T., Mehta, U., Naledi, T., & Boulle, A. M. (2006). The Western Cape Antiretroviral Programme: Monitoring Report. Provincial Government of the Western Cape.

Pienaar, D., Myer, B. L., Cleary, S., Coetzee, D. J., Michaels, D., Cloete, K., Schneider, H., & Boulle, A. M. (2006). Models of Care for Antiretroviral Service Delivery. University of Cape Town.

Cleary, S., Boulle, A. M., McIntyre, D., & Coetzee, D. J. (2004). Cost-effectiveness of antiretroviral treatment for HIV-positive adults in a South African township. .

TOP